SCHEMBL28794893

SCHEMBL28794893

CC1(C)OCC(c2ccccc2F)(C(F)F)NC1C=S

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
BACE1 P56817 1/20 0.31
BACE2 Q9Y5Z0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27854105 0.88 BACE1 (0.33) ALDH1A1BACE1BACE2
SCHEMBL27854049 0.75 BACE1 (0.32) BACE1BACE2
SCHEMBL27854022 0.72 BACE1 (0.34) BACE1BACE2
SCHEMBL363947 0.72 PGR (0.32) ALDH1A1BACE1BACE2
SCHEMBL361625 0.69 HCAR2 (0.36) ALDH1A1BACE1BACE2
SCHEMBL15643307 0.68 BACE1 (0.36) BACE1BACE2
SCHEMBL27854106 0.68 BACE1 (0.34) BACE1BACE2
SCHEMBL27886993 0.68 BACE1 (0.34) BACE1BACE2
SCHEMBL17673207 0.65 BACE1 (0.40) ALDH1A1BACE1BACE2
SCHEMBL361069 0.63 BACE1 (0.31) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102666507-A Oxazine derivatives and their use in the treatment of neurological disorders NOVARTIS AG 2012-09-12 CN disclosed
CN-102471293-A Oxazine derivatives and their use as BACE inhibitors for the treatment of neurological disorders NOVARTIS AG 2012-05-23 CN disclosed